DiviDrip · MGX

MGX — Metagenomi Therapeutics, Inc.

MGX is Metagenomi Therapeutics, Inc. (Healthcare) — a non-dividend-paying stock. Trading at $1.16. Market cap: $44M. Capital Quality Rank: 16/100 — Capital destroyer.

Stock snapshot

Price$1.16
Market cap$44M
SectorHealthcare
ExchangeNMS
Pays dividendNo

Capital Quality & fundamentals

DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.

Capital Quality Rank (1-100)16 / 100 · Capital destroyer
ROIC (TTM)-64.9%
Shareholder buyback yield-11.34%
Altman Z-score zoneDistress

About MGX

Metagenomi Therapeutics Inc is an vivo genome editing company capitalizing on its proprietary technologies to create curative genetic medicines for patients. The company leverages machine learning and artificial intelligence to enhance its signature gene editing systems. MGX-001 is its, wholly-owned development program in hemophilia A, where the company have demonstrated targeted genome editing and durable gene expression from a one-time treatment in non-human primates (NHPs) and an overall profile potentially competitive with best-in-class treatment options. MGX-001 is designed to provide curative, life-long protection from bleeding events and joint damage in adults and children with hemophilia A from a single administration.

Listed2024Employees113HQEmeryville, CASectorHealthcareWebsitemetagenomi.co

Related non-dividend companies

Other non-dividend stocks investors research alongside MGX. Peer set from Massive news + returns similarity, filtered to names we currently track.

Frequently asked

What is MGX's current stock price?

MGX (Metagenomi Therapeutics, Inc.) is currently trading at $1.16.

Does MGX pay a dividend?

MGX (Metagenomi Therapeutics, Inc.) does not currently pay a regular dividend.

What is MGX's Capital Quality Rank?

MGX has a Capital Quality Rank of 16/100 — Capital destroyer. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.

Track MGX in DiviDrip

Add MGX to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.

Data refreshed 2026-09-03. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.

Related guides

DiviDrip is a free dividend portfolio tracker built by dividend investors, for dividend investors. Try it free — no payment, no upsell, ever. Read the How-To to see how each tool fits together, or browse the Glossary for every term defined plain-English.

Disclaimer: The information provided on this website/service is for informational purposes only and does not constitute financial, investment, or legal advice. Investing in stocks involves high risk, including the loss of principal. We are not responsible for any financial losses or damages resulting from your reliance on this data. Always consult with a qualified financial professional before making investment decisions.

Trademark Notice: Twylight Crow's Dividend Tracker (formerly indexed as DiviDrip) is an independent portfolio utility. This tool is not affiliated with, authorized, endorsed by, or in any way officially connected to Dividrip.com or its international affiliates.

Contact: dividrip@twylightcrow.com© 2026 Twylight Crow